South Korea has recently unveiled a US$2bn plan to emerge as a global COVID-19vaccine production hub and become one of the top five manufacturing bases by 2025.
The sales of final dosage forms in the first half of 2021 totaled 109,5 million euros and compared to the first half of 2020 increased by 21.9 million euros.
Regulators may need to apply a risk-based approach to assessing and regulating AI, which could be informed through exchange and collaboration in ICMRA.
This assistance is of great importance for countering the consequences of the pandemic, as well as at a time when the U.S. is tightening the blockade against country.